By Will Feuer Shares of Stepan climbed in afternoon trading after the chemical manufacturer raised its dividend, reported third-quarter results and said it expects...
Vir Biotechnology, Inc. (NASDAQ:VIR) is a commercial-stage immunology company focused on infectious diseases. VIR has a portfolio of drug candidates, primarily at the Phase...